Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Behavioral Weight Loss: A Promising Treatment for Obesity in Adults with HIV.

Panza E, Wing EJ, Wing R.

AIDS Behav. 2019 Aug 27. doi: 10.1007/s10461-019-02645-y. [Epub ahead of print] Review.

PMID:
31456199
2.

Behavioral and Cardiovascular Effects of a Behavioral Weight Loss Program for People Living with HIV.

Wing RR, Becofsky K, Wing EJ, McCaffery J, Boudreau M, Evans EW, Unick J.

AIDS Behav. 2019 Apr 19. doi: 10.1007/s10461-019-02503-x. [Epub ahead of print]

PMID:
31004243
3.

Posterior reversible encephalopathy syndrome in a patient with HIV/AIDS and immune reconstitution syndrome: a case study and literature review.

Weiss ZF, Rich J, Wing EJ.

Oxf Med Case Reports. 2018 Aug 20;2018(8):omy046. doi: 10.1093/omcr/omy046. eCollection 2018 Aug.

4.

A Randomized Controlled Trial of a Behavioral Weight Loss Program for Human Immunodeficiency Virus-Infected Patients.

Becofsky K, Wing EJ, McCaffery J, Boudreau M, Wing RR.

Clin Infect Dis. 2017 Jul 1;65(1):154-157. doi: 10.1093/cid/cix238.

5.

HIV and aging.

Wing EJ.

Int J Infect Dis. 2016 Dec;53:61-68. doi: 10.1016/j.ijid.2016.10.004. Epub 2016 Oct 15. Review.

6.

Editorial Commentary: Toxoplasmosis: Cats Have It, Humans Get It, but How Much Disease Does It Cause?

Wing EJ.

Clin Infect Dis. 2016 Aug 15;63(4):476-7. doi: 10.1093/cid/ciw358. Epub 2016 Jun 26. No abstract available.

PMID:
27353664
7.

Obesity prevalence and related risk of comorbidities among HIV+ patients attending a New England ambulatory centre.

Becofsky KM, Wing EJ, Wing RR, Richards KE, Gillani FS.

Obes Sci Pract. 2016 Jun;2(2):123-127. doi: 10.1002/osp4.38. Epub 2016 May 31.

8.

Multicentric Castleman disease, Kaposi sarcoma, hemophagocytic syndrome, and a novel HHV8-lymphoproliferative disorder.

Yates JA, Zakai NA, Griffith RC, Wing EJ, Schiffman FJ.

AIDS Read. 2007 Dec;17(12):596-8, 601.

PMID:
18178978
9.

It is time to implement routine, not risk-based, HIV testing.

Beckwith CG, Flanigan TP, del Rio C, Simmons E, Wing EJ, Carpenter CC, Bartlett JG.

Clin Infect Dis. 2005 Apr 1;40(7):1037-40. Epub 2005 Feb 28.

PMID:
15824997
10.

A diagnostic dilemma in a patient receiving antiretroviral and antituberculosis therapy.

Vallabhaneni S, Kumarasamy N, Wing EJ, Flanigan TP.

AIDS Read. 2005 Feb;15(2):72-5.

PMID:
15712396
11.

Early scurvy complicating anorexia nervosa.

Christopher K, Tammaro D, Wing EJ.

South Med J. 2002 Sep;95(9):1065-6.

PMID:
12356112
12.

Listeriosis during pregnancy: a case series and review of 222 cases.

Mylonakis E, Paliou M, Hohmann EL, Calderwood SB, Wing EJ.

Medicine (Baltimore). 2002 Jul;81(4):260-9. Review. No abstract available.

13.
14.

Listeria monocytogenes: clinical and experimental update.

Wing EJ, Gregory SH.

J Infect Dis. 2002 Feb 15;185 Suppl 1:S18-24. Review.

PMID:
11865436
15.

Complementary adhesion molecules promote neutrophil-Kupffer cell interaction and the elimination of bacteria taken up by the liver.

Gregory SH, Cousens LP, van Rooijen N, Döpp EA, Carlos TM, Wing EJ.

J Immunol. 2002 Jan 1;168(1):308-15.

16.

An updated model of cell-mediated immunity--listeriosis: clinical and research aspects.

Wing EJ, Gregory SH.

Allergy Asthma Proc. 2000 Jul-Aug;21(4):209-14.

PMID:
10951886
17.

From hot dogs to CD8+ T cells: Listeria monocytogenes.

Wing EJ, Gregory SH.

Trans Am Clin Climatol Assoc. 2000;111:76-83; discussion 84. Review. No abstract available.

18.

Innate defenses in the liver during Listeria infection.

Cousens LP, Wing EJ.

Immunol Rev. 2000 Apr;174:150-9. Review.

PMID:
10807514
19.

Development of listerial meningitis during ciprofloxacin treatment.

Grumbach NM, Mylonakis E, Wing EJ.

Clin Infect Dis. 1999 Nov;29(5):1340-1. No abstract available.

PMID:
10524996
20.

Neutrophil-Kupffer-cell interaction in host defenses to systemic infections.

Gregory SH, Wing EJ.

Immunol Today. 1998 Nov;19(11):507-10.

PMID:
9818544
21.

Fas (CD95)-dependent cell-mediated immunity to Listeria monocytogenes.

Jensen ER, Glass AA, Clark WR, Wing EJ, Miller JF, Gregory SH.

Infect Immun. 1998 Sep;66(9):4143-50.

22.

IL-6 produced by Kupffer cells induces STAT protein activation in hepatocytes early during the course of systemic listerial infections.

Gregory SH, Wing EJ, Danowski KL, van Rooijen N, Dyer KF, Tweardy DJ.

J Immunol. 1998 Jun 15;160(12):6056-61.

23.

Listeria monocytogenes-infected hepatocytes are targets of major histocompatibility complex class Ib-restricted antilisterial cytotoxic T lymphocytes.

Bouwer HG, Bai A, Forman J, Gregory SH, Wing EJ, Barry RA, Hinrichs DJ.

Infect Immun. 1998 Jun;66(6):2814-7.

24.

Internalin B promotes the replication of Listeria monocytogenes in mouse hepatocytes.

Gregory SH, Sagnimeni AJ, Wing EJ.

Infect Immun. 1997 Dec;65(12):5137-41.

25.
26.
27.
28.

Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils.

Gregory SH, Sagnimeni AJ, Wing EJ.

J Immunol. 1996 Sep 15;157(6):2514-20.

PMID:
8805652
29.

Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients.

Nieto-Rodriguez JA, Kusne S, Mañez R, Irish W, Linden P, Magnone M, Wing EJ, Fung JJ, Starzl TE.

Ann Surg. 1996 Jan;223(1):70-6.

30.

Life-threatening neutropenia secondary to piperacillin/tazobactam therapy.

Gerber L, Wing EJ.

Clin Infect Dis. 1995 Oct;21(4):1047-8. No abstract available.

PMID:
8645807
31.
32.

Arginine analogues suppress antigen-specific and -nonspecific T lymphocyte proliferation.

Gregory SH, Sagnimeni AJ, Wing EJ.

Cell Immunol. 1994 Feb;153(2):527-32.

PMID:
8118880
33.
35.

IFN-gamma inhibits the replication of Listeria monocytogenes in hepatocytes.

Gregory SH, Wing EJ.

J Immunol. 1993 Aug 1;151(3):1401-9.

PMID:
8335936
36.

Reactive nitrogen intermediates suppress the primary immunologic response to Listeria.

Gregory SH, Wing EJ, Hoffman RA, Simmons RL.

J Immunol. 1993 Apr 1;150(7):2901-9.

PMID:
7681083
37.

Primary listerial infections are exacerbated in mice administered neutralizing antibody to macrophage colony-stimulating factor.

Gregory SH, Wing EJ, Tweardy DJ, Shadduck RK, Lin HS.

J Immunol. 1992 Jul 1;149(1):188-93.

PMID:
1535085
38.

Effector function of hepatocytes and Kupffer cells in the resolution of systemic bacterial infections.

Gregory SH, Barczynski LK, Wing EJ.

J Leukoc Biol. 1992 Apr;51(4):421-4.

PMID:
1564405
39.

Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect.

Cooper MH, Gregory SH, Thomson AW, Fung JJ, Starzl TE, Wing EJ.

Transplant Proc. 1991 Dec;23(6):2957-8. No abstract available.

40.

The role of colony-stimulating factors in host defenses.

Gregory SH, Magee DM, Wing EJ.

Proc Soc Exp Biol Med. 1991 Sep;197(4):349-60. Review. No abstract available.

PMID:
1871146
41.

Production of colony-stimulating factors during pneumonia caused by Chlamydia trachomatis.

Magee DM, Williams DM, Wing EJ, Bleicker CA, Schachter J.

Infect Immun. 1991 Jul;59(7):2370-5.

42.

Tumor necrosis factor, macrophage colony-stimulating factor, and interleukin 1 production within sponge matrix allografts.

Ford HR, Hoffman RA, Wing EJ, Magee DM, McIntyre LA, Simmons RL.

Transplantation. 1990 Sep;50(3):460-6.

PMID:
1698320
44.

Legionella infection in transplant patients.

Ampel NM, Wing EJ.

Semin Respir Infect. 1990 Mar;5(1):30-7. Review.

PMID:
2188318
45.

Biological effects of recombinant human GM-CSF.

Shadduck RK, Kaplan SS, Whiteside TL, Wing EJ.

Prog Clin Biol Res. 1990;352:365-74. No abstract available.

PMID:
2169633
46.

Characterization of wound cytokines in the sponge matrix model.

Ford HR, Hoffman RA, Wing EJ, Magee DM, McIntyre L, Simmons RL.

Arch Surg. 1989 Dec;124(12):1422-8.

PMID:
2686582
47.
50.

Supplemental Content

Support Center